Yale Heart Failure
@YaleHF
Official Twitter Account of the Yale Heart Failure Program | Dedicated to Improving the Lives of Patients with Heart Failure and Advancing the Field
ID:1274331005634183175
20-06-2020 13:19:32
880 Tweets
1,5K Followers
420 Following
It’s great to be back in PR. Thank you PRChapterACC for the great time. Looking forward to next time.
Exosomes from T cells are significantly altered during acute cellular allograft rejection and are a promising biomarker for detecting ACR after a solid organ transplant. Yale School of Medicine Yale Cardiology Yale Cardiac Surgery YaleTransplant m.yale.edu/cjzq
Dr. Jeff Testani is unsure if invasive devices for renal perfusion and decongestion are needed for heart failure treatment. He says most patients respond well to loop diuretics and advancing medical therapy is often enough to overcome diuretic resistance.
www-clinicalkey-com.yale.idm.oclc.org/#!/content/pla…
#GDMTWorks but does the order in which these drugs are initiated matter? 'Maybe,' says Michael H. Beasley, MD and colleagues, depending on the patient's clinical situation. However, full initiation and rapid dose optimization remain paramount. Ruey Hu, MD, MPH Ralph J. Riello III, PharmD, BCPS
sciencedirect.com/science/articl…
PROMPT-MRA: Rationale, Design, and Patient Characteristics of a Cluster-Randomized Pragmatic Trial to Improve Mineralocorticoid Antagonist Use. Katherine Clark Godiksen Ralph J. Riello III, PharmD, BCPS Tariq Ahmad MD MPH F. Perry Wilson, MD MSCE
jacc.org/doi/10.1016/j.…